Peter Rahmer

“The most recent data from both the assets that we have publicly puts their PFS in the same ballpark of about five and a half months, six months.”

“From the dose-finding portion of the study, which was what we reported on a month or so ago, it is possible that we could reach a level of maturity in those patients to start to make a point estimate of medium PFS.”

“We are very excited to share our initial vascular anomalies data with you today. you can access the press release from today the slides we are reviewing and replay of this call by going to the investor relations section of our website as a reminder during this call we will make certain statements that are considered…”

“The abstracts are slated to come out tonight around 6 o'clock or so. So the abstract will contain the top line data from an earlier time point. So we'll have PFS response rates and the PK data.”